May 24th, 2003
Overview of Dendritic-Cell Cancer Vaccines
An article from nj.com looks over the past decade of research and trials in a particular -- and very promising -- class of cancer vaccine. I've said before here that cancer is no longer a grave threat to life in developed countries. The end result of decades of well-publicized research and high levels of funding has finally come: numerous effective therapies are about to arrive in the market. This success story can be repeated for anti-aging research and regenerative medicine, but only if we manage to make these fields as popular and as well funded. Activism and advocacy are very important.